Background: DsRed the red fluorescent protein (RFP) isolated from Discosoma sp. coral holds much promise as a genetically and spectrally distinct alternative to green fluorescent protein (GFP) for application in mice. Widespread use of DsRed has been hampered by several issues resulting in the inability to establish and maintain lines of red fluorescent protein expressing embryonic stem cells and mice. This has been attributed to the non-viability, or toxicity, of the protein, probably as a result of its obligate tetramerization. A mutagenesis approach directing the stepwise evolution of DsRed has produced mRFP1, the first true monomer. mRFP1 currently represents an attractive autofluorescent reporter for use in heterologous systems.
Background
GFP and many of its spectral variants have found widespread use as genetically encoded indicators in cell biological applications, including investigating protein expression, localization and interactions [1] . They have also been used for marking cells in complex tissues in chimeras, and for tagging gene expression in targeted or transgenic regimes in whole embryos, adult animals, explants and transplants [2, 3] . In addition to the many cell biological benefits provided by increasing the number of genes encoding fluorescent protein species and extending the spectrum of available colors to longer (red) wavelengths of the spectrum, access to red fluorescent protein (RFP) variants would offer benefits for genetically and spectrally-distinct imaging of multiple cell populations in complex tissues [2, 4] .
All genetically-encoded coelenterate-derived fluorescent proteins cloned to date display some form of quaternary structure [5] . The weak tendency of Aequorea victoria green fluorescent protein (GFP) to dimerize has not impeded its use in exogenous systems. In contrast the obligate tetramerization of the most popular RFP DsRed [6] , isolated from Discosoma sp., has impeded its widespread use in mice [3] . In addition to its obligate tetramerization, the evolution of DsRed to a generally applicable and robust tool has been hampered by several critical problems, including its slow and incomplete maturation [7] .
An alternative approach to overcoming the shortcomings of DsRed has been to continue the search for DsRed homologues in sea corals and anemones [8] [9] [10] . This approach has yielded several novel red-shifted proteins, however the more fundamental problem of tetramerization still exists and needs to be overcome. Therefore it appears likely that a mutagenesis approach focused on a single tetrameric RFP and designed to sequentially render it dimeric and then monomeric while retaining fluorescence quantum yield and extinction coefficient, is key to achieving progress in the field [11] .
Attempts, to mutagenize the DsRed coding sequence to improve the rate and or extent of maturation have resulted in several variants including DsRed2. Unfortunately DsRed2 has provided only modest improvements and has not effectively eradicated the apparent 'toxicity' of DsRed [12] . Additional engineered variants, including DsRed.T1, DsRed.T3 and dimer2 have superceded DsRed2, as they have faster more complete maturation [11, 13] . However, since these proteins still form obligate dimers, the heterogeneity of protein localization (observed as 'clumps' within cells) has not been overcome [13, 14] .
Although many dimeric DsRed variants have found widespread use in other organisms including yeast, worms, fruitflies and zebrafish, several investigators, including ourselves, have not previously been successful in using them in mice [3] . Recently mice with widespread conditionally activated DsRed.T3 expression have been reported [15] . Interestingly though high-resolution imaging of embryonic stem cells and cells in chimeras that exhibit constitutive expression of DsRed.T3, or of related dimeric DsRed variants, reveals heterogeneous expression within cells, and in particular, punctate staining in a perinuclear region, possibly the Golgi (our unpublished observations). Although reduced in intensity, this subcellular localization is reminiscent of that observed with tetrameric DsRed variants. It is therefore probable that dimeric DsRed variants are not the optimal starting point for RFPs used in mouse transgenic and gene targeting regimes.
Moreover the available dimeric DsRed variants have not resolved the issue of incorporating RFPs into protein fusions that can, for example, be used for in vivo imaging at subcellular resolution [12] , therefore necessitating the development of monomeric RFPs which may provide improved performance and yield developmental neutrality when incorporated into fusions.
The first true monomer designated mRFP1 (monomeric RFP 1), was reported a few years ago [11] . The stepwise evolution of the DsRed sequence to generate mRFP1 involved mutations that first increased the speed of maturation, then mutations which resulted in the breaking of each subunit interface, and then a further round of mutations resulting in restoration of fluorescence. This directed evolution of an RFP to a monomer resulted in the introduction of a total of 33 amino acid substitutions [11] . mRFP1 has been reported to participate in, but not impair, the function of various fusion proteins in cases where both the tetrameric and dimeric DsRed variants were unable to do so. This makes mRFP1 attractive for use in mice both in its native form and as part of a fusion protein.
Furthermore, mRFP1 has recently served as the template for further mutagenesis directed at improving its performance in N-terminal protein fusions, fluorescence quantum yield and extinction coefficient, photostability and/or in providing a variety spectral variants [16] . This has resulted in the next generation of monomers, which include a battery of spectrally-distinct DsRed variants spanning the spectrum from green (mHoneydew), through yellow (mBanana) to a range of reds (mOrange, mStrawberry, mCherry). Therefore monomeric RFPs based on DsRed currently represent the most attractive geneticallyencoded red fluorescent proteins for use in mice. However, the developmental neutrality and fluorescent intensity of monomeric RFPs has not been investigated in vivo in transgenic or gene targeting applications mice.
Results
We have investigated the expression and germline transmission of native mRFP1 in embryonic stem cells and mice. This is an essential prerequisite to using the available suite of DsRed-derived monomeric RFPs in fusions as reporters for high-resolution in vivo imaging, and in particular, as fusion proteins exhibiting subcellular localization and acting as segmental markers of 3-dimensional space.
As a first step we cloned the mRFP1 gene into a vector permitting widespread expression in a variety of cells types in culture and in vivo in mice. The mRFP1 coding sequence was engineered to contain a Kozak consensus sequence at its 5' end and subsequently introduced into pCAGGS a vector utilizing the chicken beta actin promoter and SV40 immediate early enhancer combination, designed to drive high-level constitutive gene expression in ES cells, embryos and adult mice [17, 18] . Standard protocols were used to establish stable CAG::mRFP1 transgenic lines of ES cells constitutively expressing mRFP1.
Fluorescent colonies (CAG::mRFP1 transgenic) were identified and picked under an epifluorescence stereo dissecting microscope. Clones were passaged in 96-well plates, and scored for the maintenance and extent of red fluorescence with maintenance in culture. Clones that failed to meet these criteria were discarded from further analysis. Thereafter only clones exhibiting robust transgene expression in vitro under both stem cell and differentiation conditions were further analyzed for level and heterogeneity of red fluorescence by flow cytometry as described previously for GFP-variants [19] . Only those clones exhibiting high levels of homogenous expression were selected for further analysis. Sustained strong homogenous red fluorescence and retention of normal ES cell morphology when grown on either gelatin-coated plates or mouse embryo fibroblast feeders was a prerequisite feature of these cells
We then co-cultured three transgenic ES cell lines expressing different fluorescent proteins, namely; CAG::ECFP, CAG::EGFP and CAG::mRFP1 along with wild type (nonfluorescent) ES cells, and then visualized fluorescence in resulting chimeric colonies (Fig. 1) . The different fluorophores could easily be distinguished both with standard filter sets using epifluorescence optics and confocal microscopy, without the need for special image processing such as spectral deconvolution or linear unmixing [20] . We also noted that comparable levels of fluorescence were produced as all three color variants produced fluorescent signal within the same dynamic range.
Having established the neutrality of widespread mRFP1 expression in ES cells, we went on to use ES cell mediated transgenesis through the generation of germline transmitting chimeras to introduce the CAG::mRFP1 transgene into mice. As a first step to test the extent of expression of the transgene in embryos, we generated 4n (tetraploid) wild type <-> mRFP1 ES cell derived chimeras [21] , exactly as described previously [3] . Resulting, completely ES cellderived embryos exhibited widespread mRFP1 expression, indicating that the level of expression was sufficiently strong to be visualized, that the transgene was not silenced and that development was able to proceed normally to midgestation (data not shown). To produce germline transmitting chimeric adult animals, we next generated diploid wild type <-> mRFP1 ES cell chimeras that were allowed to go to term. The CAG::mRFP1 transgene was transmitted to F1 offspring in a Mendelian fashion, suggesting that widespread mRFP1 expressing is compatible with normal development and fertility. Two ES cell lines were taken germline and shown to produce an equivalent intensity and range of fluorescence, therefore data from only one line are shown.
Wide field epifluorescent and laser scanning confocal microscopy was used to image this constitutively expressed transgene reporter in preimplantation stage mouse embryos hemizygous (Tg/+) for the CAG::mRFP1 transgene ( Fig. 2 and additional files) . Such non-invasive visualization in living preparations allowed us to acquire high-magnification, sequential optical sections (z-stacks) that were used to generate high-resolution anatomical, volumetric images of embryos. To do this, stacks of sequential optical sections were computationally reconstructed into 3-dimensional (3D) projections. This methodology was used to generate 3D image sets, and is illustrated here by imaging whole mouse embryos at the 1-cell stage and blastocyst stage. These data sets can be computationally manipulated in various ways including for the visualization of individual xy slices from a z-stack (Fig. 2B ,C,K and 2L and additional files), or of rendered images from the full (Fig. 2D) , or partial z-stack ( Fig. 2E  and 2M ). It should be noted that even using epifluorescence imaging CAG::mRFP1 embryos were clearly distinguished from stage-matched CAG::EGFP embryos (Fig.  2G-I ).
Wide field microscopic imaging of later stage hemizygous embryos illustrated the robust, homogenous and widespread expression of mRFP1 from early postimplantation, embryonic day (E) 6.5 (Fig. 3A) to later fetal stages in both the embryo proper and extraembryonic lineages, including the placenta (Fig. 3E-F) . Dissection of organs from fetuses confirmed widespread red fluorescence in CAG::mRFP1/+ organs contrasted with a lack of signal observed in non-transgenic littermates (Fig. 3G and 3H ).
Examination of newborn animals revealed strong widespread expression of mRFP1 in the skin of hemizygous CAG::mRFP/+ transgenics and demonstrated that this red fluorophore can be distinguished from green fluorescence observed in CAG::EGFP/+ transgenics, and from nontransgenic littermates by standard macroscopic visualization using standard filter sets and epiflourescent excitation (Fig. 4) .
Further analysis of various adult organs, including the peritoneum, heart, lung, eye, brain, liver, pancreas, spleen and kidney, that were freshly obtained from CAG::mRFP1/ + adult animals revealed robust and widespread fluorescence (Fig. 5) , as has been reported for animals expressing GFP-based fluorescent proteins under the regulation of the CAG promoter. We also noted that newborn pups, or bald skin and tissues expressing mRFP1, exhibit a pink . This is particularly evident in albino animals (tails in Fig. 4C ), and in unpigmented organs such as the brain and pancreas ( Fig. 5E and 5G ). We believe this results from mRFP1 being a red fluorphore with a spectrum closer to the visible range, so that it can be visualized as a pink pigmentation under daylight or bright field conditions. Consequently, newborn CAG::mRFP1 pups can be genotyped based on their pink pigmentation, alleviating the need to image them under epifluorescent conditions.
Moreover we succeeded in breeding the CAG::mRFP1 transgene to homozygosity. Homozygous animals retained developmental potential and therefore colonies of the strain are routinely maintained in the homozygous state. To date, we have observed no noticeable reduction in fluorescence or fertility for over four generations on 
Discussion
We have established the applicability of monomeric RFPs as an alternative spectrally-distinct genetically-encoded fluorescent reporter to GFP and its variants. Now monomeric DsRed variants can be used in vivo in mice along side GFP variants to differentially label single cells or different populations of cells.
Advances in optical imaging modalities, and the development of ex vivo embryo or explant culture systems, have evolved alongside the increasing availability of genetically-encoded fluorescent proteins permitting dynamic in vivo imaging of living specimens. Two major limitations in the application of genetically-encoded fluorescent protein technology in mice, have been the lack of fluorescent proteins in the longer wavelength (red) part of the spectrum, and the absence of a fluorescent protein that is genetically distinguishable from GFP. DsRed, the coelenterate derived RFP, has offered the potential to solve both these problems, but original variants, which function as obligate tetramers and dimers, have exhibited 'toxicity', limiting their use in heterologous systems.
Our work demonstrates the developmental neutrality of mRFP1, the first true monomeric RFP, in ES cells and mice. The strain of mice we have generated exhibits widespread mRFP1 expression, providing a novel reagent for live imaging of red fluorescent cells in a genetically tractable mammalian model organism. CAG::mRFP1 animals represent a resource for analyzing development and disease in mouse embryos and adults. They can also be used as tagged populations of cells in chimeras, in addition to transplantation and cell isolation experiments. Moreover RFP cells can easily be distinguished from GFP, or GFP 
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Widespread RFP expression in adult organs To date all fluorescent proteins isolated from diverse anthozoan species suffer from obligate tetramerization and will require efforts similar to the evolution of mRFP1 to produce widely useful tools. Our demonstration of the developmental neutrality of widespread mRFP1 expression paves the way for the incorporation of monomeric RFPs into mouse transgenic and gene targeting approaches [2] . Our data on mRFP1 suggest that its mutagenized derivatives will also be amenable to use in mice. If so, there should now be at least six new spectral variant monomeric FPs based on DsRed that can be used in mice. Key applications of the proliferation of spectral variant FPs will include discriminating different cells, transcriptional activities and/or fusion proteins.
Conclusion
Our work demonstrates the use of monomeric RFPs in mice and provides the basis for future efforts designed to incorporate RFPs into protein fusions that can be used as spectrally-distinct subcellularly-localized tags permitting high-resolution live imaging in vivo [12, 22] . The ongoing development of mouse strains expressing subcellularlylocalized protein fusions incorporating RFPs, and contrasting with GFP-variants will be essential for visualizing 4-dimensional (3-dimensions over time) anatomy and tracking cell position, morphology and behavior in vivo.
Methods

Vector construction
The mRFP1 coding sequence was amplified by PCR using primers 5'RFP (5'-cgtagaattcgccaccaatggctagcatgactgg) and 3'RFP (5'-gcacgaattcgggcgccggtggagtggcggcc) using Pfx Polymerase (Invitrogen). The resulting product was cloned into the EcoRI site of pCAGGS to generate pCXmRFP1. Transient transfection of Cos-7 cells using Fugene 6 Transfection Reagent as per manufacturer's recommendations (Roche) was used to evaluate pCX-mRFP1, and verify that it produced robust red fluorescence.
Generating transgenic ES cells
Transgenic ES cell lines constitutively expressing mRFP1 were generated by co-electroporation of SalI linearized pCX-mRFP1 construct and a circular PGK-Puro-pA plasmid conferring transient puromycin resistance. Puromycin selection was carried out exactly as described previously [18] . Thereafter cells were passaged according to standard protocols.
Mouse breeding
Two lines of CAG::mRFP1 ES cells were used for chimera generation by injection into C57BL/6 blastocysts using standard procedures [23] . Chimeras were mated to outbred ICR and inbred 129/Tac mice (Taconic, Germantown, NY) for germline transmission and subsequent maintenance of the lines. After germline transmission, both transgenes were bred to, and maintained at, homozygosity, suggesting that the sites of transgene integration were not perturbing essential gene function and that high levels of protein expression were non-toxic. Animals from both lines retained widespread homogenous fluorescence in all subsequent generations tested and therefore data was pooled.
Embryo collection
Preimplantation embryos were recovered in M2 media and subsequently cultured under oil in a tissue culture incubator gased at 5% CO2 in KSOM media. Postimplantation embryos and organs were dissected either in HEPES buffered DMEM containing 10% fetal calf serum or PBS containing 0.1% BSA, and cultured in media comprising 50% rat serum, 50% DMEM/F12 supplemented with Lglutamine.
Image acquisition
Also although mRFP1 has been shown to have a lower extinction coefficient, quantum yield, and photostability than native DsRed or DsRed.T3, mRFP1 has been shown to mature over ten fold faster, so that it shows similar brightness in living cells. In addition, the excitation and emission peaks of mRFP1 (584 and 607 nm respectively) are 25 nm red-shifted from DsRed, which should confer greater tissue penetration and spectral separation from autofluorescence and other fluorescent proteins. All images presented in the figures are of living embryos or freshly dissected (unfixed) tissues maintained under physiological conditions. Wide-field images were acquired with an AxioCam MRc camera attached to a Leica MZ16FA stereo-dissecting microscope or a Zeiss Axiovert 200M inverted microscope equipped with epifluorescent illumination using appropriate filter sets (Chroma). Laser scanning confocal data was acquired in single-track mode using a Zeiss LSM510 META on a Zeiss Axiovert 200M. Fluorophores were excited with a 405 nm diode laser (ECFP), 488 nm Argon laser line (EGFP) and a 543 nm HeNe laser (mRFP1). Objectives used were a C-apochromat 40×/NA1.2, plan-apochromat 20×/0.75 and a fluar 5×/0.25. Confocal images were acquired as z-stacks comprising sequential optical x-y sections taken at 1-2 µm zintervals.
Image processing
Raw data was processed using Zeiss AIM software (Carl Zeiss Microsystems at http://www.zeiss.com/), and Voloc-ity (Improvision at http://www.improvision.com/). Reanimation of data to generate movies of time-lapses or rotations was performed using QuickTime Pro (Apple Computer, Inc at http://www.apple.com/quicktime/).
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Footnote
The CAG::mRFP1 mice described in this paper will be made available from the Jackson Laboratories Induced Mutant Resource (http://www.jax.org/imr/index.html) as stock number #5645.
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